Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression analysis of Huh7 cells treated with human or mouse erythroferrone (ERFE)

ABSTRACT: Analysis of overall gene expression changes in Huh7 cells after treatment with mouse or human erythroferrone (ERFE)

ORGANISM(S): Homo sapiens

PROVIDER: GSE118367 | GEO | 2018/08/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression analysis of Huh7 cells treated with human or mouse erythroferrone (ERFE)

Project description:Gene expression analysis of Huh7 cells treated with human or mouse erythroferrone (ERFE)

| PRJNA485341 | ENA

Osteocytes produce erythroferrone to regulate liver hepcidin during stress erythropoiesis

Project description:The bone marrow microenvironment has a variety of cell types. Osteocytes regulate bone remodeling and were described to participate in bone marrow functions. However, their role in regulating red blood cell production is not known. To understand their role in red blood cell regulation we isolated osteocytes from mice after acute hemorrhagic anemia and performed bulk RNAseq in comparison to controls. We identified the top upregulated gene in osteocytes as Fam132b or erythroferrone (Erfe). ERFE is known to be produced by erythroblasts in response to erythropoietin (EPO) and mediates hepcidin suppression in the liver during stress erythropoiesis. In our model ERFE expression was 16-fold higher in osteocytes isolated from mice after phlebotomy compared to control mice. The expression level of ERFE in osteocytes was similar to that described in erythroid precursors. Expression in osteocytes was also induced by hypoxia in vitro. In vivo experiments confirmed these findings. When Erfe-/- mice were transplanted with WT BM (thus only the BM can produce Erfe), the hepcidin suppression in the liver was significantly less then in WT mice, when both the osteocytes and the BMcan produce Erfe. Osteocyte Erfe is produced through their Epo receptors sensing the hypoxia. So, we tested if eliminating the Epo receptors from bone cells only would have an effect on liver hepcidin and found that these mice could not suppress liver hepcidin as much as control animals did. These two experiments confirmed our hypothesis, that osteocytes produce Erfe in response to EPO and that the Erfe they release has a significant contribution to suppressing liver hepcidin production. The lowered hepcidin levels make iron available to increase red cell production. Thus osteocytes actively participate in regaining the balance of the bone marrow by increasing red cell production after bleeding.

2026-04-22 | GSE241575 | GEO

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome (RNA-Seq)

Project description:Myelodysplastic syndromes (MDS) with ring sideroblasts are hematopoietic stem celldisorders with erythroid dysplasia and mutations in the SF3B1 splicing factor gene. MDS patientswith SF3B1 mutations often accumulate excessive tissue iron, even in the absence oftransfusions, but the mechanisms that are responsible for their parenchymal iron overload areunknown. Body iron content, tissue distribution, and the supply of iron for erythropoiesis arecontrolled by the hormone hepcidin, which is regulated by erythroblasts through secretion of theerythroid hormone erythroferrone (ERFE). Here, we identified an alternative ERFE transcript inMDS patients with the SF3B1 mutation. Induction of this ERFE transcript in primary SF3B1-mutated bone marrow erythroblasts generated a variant protein that maintained the capacity tosuppress hepcidin transcription. Plasma concentrations of ERFE were higher in MDS patientswith a SF3B1 gene mutation than in patients with SF3B1 wild-type MDS. Thus, hepcidinsuppression by a variant erythroferrone is likely responsible for the increased iron loading inpatients with SF3B1-mutated MDS, suggesting that ERFE could be targeted to prevent ironmediated toxicity. The expression of the variant ERFE transcript that was restricted to SF3B1-mutated erythroblasts decreased in lenalidomide-responsive anemic patients, identifying variantERFE as a specific biomarker of clonal erythropoiesis.

2019-06-18 | GSE132836 | GEO

DNA microarray analysis of Huh7 and JMJD5KO Huh7 cells.

Project description:To understand the roles of JMJD5 in liver cells, we performed DNA microarray analysis by using JMJD5KO Huh7 cells. We noticed that several transcriptional factors involved in differentiation to hepatocytes were down-regulated in JMJD5KO Huh7 cells compared to parent Huh7 cells..

2016-01-23 | GSE73491 | GEO

Transcriptome data of Huh7 cells treated with glucose or fructose

Project description:The transcriptome sequencing compared gene expression differences in Huh7 cells treated with glucose versus fructose. At the nutrient level, fructose treatment alone did not induce severe endoplasmic reticulum (ER) stress compared to glucose. However, upon KHK-C overexpression, fructose treatment led to significant ER stress. At the genetic level, glucose treatment did not trigger ER stress even with KHK-C overexpression, whereas fructose treatment under the same conditions resulted in pronounced ER stress. Additionally, Aldob knockdown further exacerbated ER stress. In summary, our findings suggest that in Huh7 cells, KHK-C-mediated phosphorylation of fructose into fructose-1-phosphate (F1P) leads to intracellular F1P accumulation, which drives severe ER stress.

2026-03-31 | GSE293320 | GEO

Expression levels of mature miRNAs from Huh7 cell treated with ROCK inhibitor

Project description:We used microarray to determine the miRNA whose expression was changed at 12 hours after Y27632 treatment Two-condition experiment; Huh7 control vs Huh7 treated with Y27632 for 12 hours

2014-04-21 | E-GEOD-33876 | biostudies-arrayexpress

shControl Huh7 and shARID1A Huh7 cells without or with rapamycin treatment

Project description:shControl Huh7 and shARID1A Huh7 cells without or with rapamycin treatment

| PRJNA667865 | ENA

Expression data from xenograft HuH7 mice treated with Zinc Acexamate and HuH7 cell line

Project description:the impact of Zn supplementation was evaluated in a xenograft mouse model of HCC, with subsequent analysis of tumor gene expression profiles The aim was to compare the effects of Zinc supplementation in a in vivo model of HuH7 xenograft mice treated with Zinc Acexamate vs vehicle-treted mice and in HuH7 cell line between different concentrations of Zinc Acexamate

2025-01-01 | GSE277019 | GEO

Microarray analysis of Huh7 cells treated with IFNa2, OSM or IFNa2 combined with OSM

Project description:OSM increases the antiviral effect of IFNα in Huh7 cells infected with hepatitis A virus (HAV) or HCV replicon and synergizes with IFNα in the induction of antiviral genes 16 samples. Four replicates for each experimental condition. 72 hours of treatment in DMEM supplemented with 2% FBS.

2009-01-20 | E-GEOD-13046 | biostudies-arrayexpress

RNAseq analysis of Huh7 cells upon stable-knockdown of L1 elements

Project description:L1 elements are repeat elements known to get activated during hepatocarcinogenesis. We have knocked-down expression of L1 elements using shRNA targeting L1-ORF1 in Huh7 cell line and a control non-targeting cell line was also generated. Influence of L1 knockdown on overall cellular transcritome was then analysed by RNAseq followed by pathway analysis. Overall, a crosstalk between L1 elements and TGFbeta signaling pathway is observed.

2023-01-21 | GSE126615 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data